NEW! 2013 High Risk-High Reward Research Awards Announced!
The NIH has announced 78 awards to support exceptional innovation in biomedical research. In 2013, the NIH is awarding 12 Pioneer Awards, 41 New Innovator Awards, 10 Transformative Research Awards, and 15 Early Independence Awards. The total funding, which represents contributions from the NIH Common Fund and multiple NIH institutes and centers, is approximately $123 million. Read the press release here.
HRHR researchers named as 2013 Allen Distinguished Investigators
Two NIH High Risk – High Reward Investigators, Jeff Gore, a 2012 New Innovator from MIT, and Markus Covert, a 2009 Pioneer from Stanford University, were selected as 2013 Allen Distinguished Investigators.
Read more here
Two HRHR researchers awarded world’s largest brain research prize
Americans, Karl Deisseroth, a 2005 Pioneer Awardee, and 2012 Transformative Research Awardee, and Edward S. Boyden, a 2007 New Innovator, and 2012 Transformative Research Awardee and four European scientists were awarded the 2013 prize for their contributions to the development of “optogenetics.”
Read more here
The NIH Director's New Innovator Award addresses two important goals: stimulating highly innovative research and supporting promising new investigators. Many new investigators have exceptionally innovative research ideas, but not the preliminary data required to fare well in the traditional NIH peer review system. As part of NIH's commitment to increasing opportunities for new scientists, it has created the NIH Director's New Innovator Award to support exceptionally creative new investigators who propose highly innovative projects that have the potential for unusually high impact. This award complements ongoing efforts by NIH and its institutes and centers to fund new investigators through R01 grants and other mechanisms.
The NIH Director's New Innovator Award program is different from traditional NIH grants in several ways. It is designed specifically to support unusually creative new investigators with highly innovative research ideas at an early stage of their career when they may lack the preliminary data required for an R01 grant. The emphasis is on innovation and creativity; preliminary data are not required, but may be included. No detailed, annual budget is requested in the application. The procedure for evaluating applicants' qualifications is distinct from the traditional NIH peer review “study section” process and will emphasize the individual’s creativity, the innovativeness of the research approaches, and the potential of the project, if successful, to have a significant impact on an important biomedical or behavioral research problem.
Archived Program Highlights
|New material holds promise for drug delivery, medical implants
|Location, location, location: Scientists uncover new information about brain stem cell environment|
|New Tools to Correct Brain Activity|